ReviewChinese medicine2025
Mechanistic insights into the multi-target anti-atherosclerotic actions of rhubarb: a traditional remedy revisited.
Review in Chinese medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Analysis of Research Progress on the Chemical Constituents and Pharmacological Activities of Er-Shiwei Roudoukou Wan.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Rhubarb as a Potential Component of an Anti-Inflammatory Diet.Foods (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Atherosclerosis (AS), a chronic inflammatory vascular disease, underlies the pathogenesis of most cardiovascular disorders. Its pathologic features include endothelial damage, inflammatory response, lipid plaque formation and rupture, thrombosis, and arterial stenosis occlusion. Severe AS can lead to the development of stroke, myocardial infarction and other adverse outcomes. Therefore, it is essential to choose reliable and effective drugs to control or alleviate the deterioration of AS. Rhubarb is a kind of Chinese herb in the Polygonaceae family, with the scientific name of Rheum palmatum L. Numerous studies in recent years have confirmed that the Chinese herb rhubarb possesses a wide range of pharmacological activities against a variety of diseases, including inflammation, cancer, digestive disorders, and cardiovascular diseases. This paper focuses on the different pharmacological impacts and possible action mechanisms of the main active constituents of rhubarb (including anthraquinones, anthracenes, stilbenes, tannins, etc.) in the treatment of AS, providing useful references for the treatment of AS and innovative pharmaceutical development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.